We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
-3.69%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$314M
AUM Growth
+$19.4M
Cap. Flow
+$26M
Cap. Flow %
8.29%
Top 10 Hldgs %
50.17%
Holding
162
New
29
Increased
30
Reduced
25
Closed
22

Top Buys

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$6.48M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$4.65M
4
JNJ icon
Johnson & Johnson
JNJ
+$3.54M
5
BIP icon
Brookfield Infrastructure Partners
BIP
+$2.72M

Top Sells

Rank Stock Value
1
MITA
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
+$4.69M
2
ZGNX
Zogenix, Inc.
ZGNX
+$2.19M
3
SDIG
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
+$2.1M
4
DNMR
Danimer Scientific, Inc.
DNMR
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.27M

Sector Composition

Rank Sector Weight
1 Healthcare 28.01%
2 Financials 21.94%
3 Materials 19.81%
4 Communication Services 5.75%
5 Real Estate 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRIV
26
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$3.41M 1.09%
350,000
– –
ABBV icon
27
AbbVie
ABBV
$449B
$3.25M 1.03%
20,037
+10,037
+100% +$1.46M
KAIR
28
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$3.25M 1.03%
330,963
-14,500
-4% -$142K
EIGR
29
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.23M 1.03%
12,976
+2,393
+23% +$378K
BMY icon
30
Bristol-Myers Squibb
BMY
$125B
$3.1M 0.99%
42,409
– –
BIP icon
31
Brookfield Infrastructure Partners
BIP
$18.1B
$2.98M 0.95%
+67,500
New +$2.72M
KKR icon
32
KKR & Co
KKR
$87.8B
$2.92M 0.93%
50,000
– –
GLHAW
33
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 0.92%
250,000
– –
REGN icon
34
Regeneron Pharmaceuticals
REGN
$70.7B
$2.79M 0.89%
4,000
-2,000
-33% -$1.27M
JPM icon
35
JPMorgan Chase
JPM
$907B
$2.76M 0.88%
20,220
+7,300
+57% +$1.08M
CTIC
36
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.6M 0.83%
556,687
+335,608
+152% +$1M
AB icon
37
AllianceBernstein
AB
$3.53B
$2.38M 0.76%
50,500
– –
RHP icon
38
Ryman Hospitality Properties
RHP
$8.03B
$2.26M 0.72%
24,400
+12,000
+97% +$1.07M
INVA icon
39
Innoviva
INVA
$1.6B
$2.23M 0.71%
115,269
– –
BBIO icon
40
BridgeBio Pharma
BBIO
$16B
$2.04M 0.65%
+200,893
New +$2.06M
XENE icon
41
Xenon Pharmaceuticals
XENE
$6.54B
$2.03M 0.65%
66,500
-19,988
-23% -$598K
MRK icon
42
Merck
MRK
$313B
$2.01M 0.64%
24,500
+23,200
+1,785% +$1.83M
PMGM
43
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.98M 0.63%
200,000
– –
TWLVW
44
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.61%
166,666
-5,000
-3% -$1.74K
SRRA
45
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.79M 0.57%
+55,758
New +$1.6M
KAIRW
46
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.6M 0.51%
139,278
-7,250
-5% -$2.46K
GREE
47
Greenidge Generation Holdings
GREE
$34.8M
$1.59M 0.51%
18,506
– –
RDUS
48
DELISTED
Radius Health, Inc.
RDUS
$1.57M 0.5%
+178,218
New +$1.35M
CHRS icon
49
Coherus Oncology
CHRS
$214M
$1.52M 0.48%
117,555
+15,000
+15% +$191K
AVDL
50
DELISTED
Avadel Pharmaceuticals
AVDL
$1.42M 0.45%
207,663
-50,535
-20% -$347K
1
2
3 4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q1 2022 Portfolio in Review

As of Q1 2022, David M. Knott Jr held 162 positions worth $314M, up 6.6% from $295M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

David M. Knott Jr deployed $26M of net new capital in Q1 2022, opening 29 new positions and adding to 30 existing holdings. Its largest new stake was iPath Series B S&P 500 VIX Short-Term Futures ETN: 15,625 shares worth $6.42M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 23% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Coliseum Acquisition Corp. Class A Ordinary Share, an estimated $4.69M trimmed.

  • David M. Knott Jr's largest Q1 2022 buy was iPath Series B S&P 500 VIX Short-Term Futures ETN: 15,625 shares worth $6.42M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q1 2022, an estimated $6.48M increase.
  • David M. Knott Jr's biggest Q1 2022 reduction was Coliseum Acquisition Corp. Class A Ordinary Share, cutting an estimated $4.69M.
  • David M. Knott Jr fully exited Zogenix, Inc. in Q1 2022, selling an estimated $2.19M.
  • David M. Knott Jr's ten largest holdings make up 50% of its $314M portfolio in Q1 2022.
  • David M. Knott Jr opened 29 new positions and closed 22 in Q1 2022.
  • David M. Knott Jr's portfolio value rose 6.6% quarter-over-quarter to $314M.

Based on David M. Knott Jr's 13F filing for Q1 2022, filed 16 May 2022.